Aggressive B-Cell Lymphoma

conference reporter

by Frederick L. Locke, MD

At the 62nd ASH Annual Meeting and Exposition, a number of abstracts focused on strategies to optimize chimeric antigen receptor (CAR) T-cell thera......READ MORE

conference reporter

by Frederick L. Locke, MD

Several abstracts presented at the 62nd ASH Annual Meeting and Exposition focused on cellular immunotherapy for relapsed aggressive B-cell lymphoma......READ MORE

conference reporter

by David B. Miklos, MD, PhD

At the 62nd ASH Annual Meeting and Exposition, researchers described varying strategies to address unmet needs in the treatment of aggressive B-cel......READ MORE

conference reporter

by Jeremy S. Abramson, MD, MMSc

Several abstracts presented at the 62nd ASH Annual Meeting and Exposition focused on novel and emerging treatment approaches in aggressive B-cell l......READ MORE

conference reporter

by Jeremy S. Abramson, MD, MMSc

Several abstracts presented at the 62nd ASH Annual Meeting and Exposition focused on treatments for patients with high-risk variants of aggressive ......READ MORE